Literature DB >> 10600580

Women with epilepsy: their views about their treatment and care.

P Crawford1, P Lee.   

Abstract

This study reports the results of a questionnaire survey of female members of the British Epilepsy Association. The women were asked about their epilepsy and its management. A questionnaire was sent to 6000 BEA women members of whom 1855 (31%) replied. The majority of women (89%) stated they currently take older antiepileptic medications, either as monotherapy or in combination with others. Newer antiepileptic drugs were prescribed to 30% of women. The most frequently mentioned antiepileptic drug side-effects were tiredness and forgetfulness. Seventy percent of the sample considered that the lack of energy had at least a moderate impact on their life. Thirty-eight percent of women would have liked better seizure control whilst 32% agreed that they would prefer to change to a medication with fewer side-effects. However, 49% were reluctant to change their medication. Fifty-nine percent stated that they see their hospital specialist regularly whilst half the sample (49%) saw their GP regularly. Hospital specialists on the whole, played a more active role in the management of epilepsy than GPs. Many women (68%) felt that their GP's main task appeared to be to write prescriptions and 40% felt that they knew more about their epilepsy than their GP. However, the women generally perceived that their GP or hospital specialists were sympathetic to their condition and their concerns. Copyright 1999 BEA Trading Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600580     DOI: 10.1053/seiz.1999.0328

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  1 in total

1.  A 'real puzzle': the views of patients with epilepsy about the organisation of care.

Authors:  Glyn Elwyn; Stuart Todd; Richard Hibbs; Ajay Thapar; Peter Edwards; Amanda Webb; Clare Wilkinson; Mike Kerr
Journal:  BMC Fam Pract       Date:  2003-04-22       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.